The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT

Rheumatology (United Kingdom)

Volumn 51, Issue 8, 2012, Pages 1484-1491

  Okamura, Koichi ^a   Yonemoto, Yukio ^a   Arisaka, Yukiko ^a   Takeuchi, Kimihiko ^a,b   Kobayashi, Tsutomu ^a   Oriuchi, Noboru ^a   Tsushima, Yoshito ^a   Takagishi, Kenji ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Isesaki Fukushima Hospital   (Japan)

Author keywords

Anti TNF; Disease activity; FDG PET; Rheumatoid arthritis; SUV; Treatment response

Indexed keywords

C REACTIVE PROTEIN; ETANERCEPT; FLUORODEOXYGLUCOSE F 18; INFLIXIMAB; METHOTREXATE; PREDNISOLONE;

ADULT; AGED; ANKLE; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE ACTIVITY; ELBOW; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HIP; HUMAN; KNEE; MALE; MUSCULOSKELETAL SYSTEM PARAMETERS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SHOULDER; TREATMENT DURATION; WRIST;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84865182162     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes064     Document Type: Article

References (17)

1. Wunder A, Straub RH, Gay S, Funk J, Müller-Ladner U. Molecular imaging: novel tools in visualizing rheumatoid arthritis. Rheumatology 2005;44:1341-9.
2. McQueen FM, Ostergaard M. Established rheumatoid arthritis-new imaging modalities. Best Pract Res Clin Rheumatol 2007;21:841-56.
3. Beckers C, Jeukens X, Ribbens C et al. (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging 2006; 33:275-80.
4. Palmer WE, Rosenthal DI, Schoenberg OI et al. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]- fluoro-2-deoxy-D-glucose. Radiology 1995;196:647-55.
5. Polisson RP, Schoenberg OI, Fischman A et al. Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:819-25.
6. Goerres GW, Forster A, Uebelhart D et al. F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis. Clin Nucl Med 1995; 31:386-90.
7. Fonseca A, Wagner J, Yamaga LI et al. (18) F-FDG PET imaging of rheumatoid articular and extraarticular synovitis. J Clin Rheumatol 2008;14:307.
8. Chaudhari AJ, Bowen SL, Burkett GW et al. High-resolution (18)F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritis. Eur J Nucl Med Mol Imaging 2010;37:1047.
9. Kubota K, Ito K, Morooka M et al. Whole-body FDG-PET/ CT on rheumatoid arthritis of large joints. Ann Nucl Med 2009;23:783-91.
10. Beckers C, Ribbens C, André B et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med 2004;45:956-64.
11. Ju JH, Kang KY, Kim IJ et al. Visualization and localization of rheumatoid knee synovitis with FDG-PET/CT images. Clin Rheumatol 2008;27(Suppl. 2):S39-41.
12. Kiely PD, Deighton C, Dixey J et al. Biologic agents for rheumatoid arthritis-negotiating the NICE technology appraisals. Rheumatology 2012;51:24-31.
13. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
14. DASSCORE.NL:Homeof the DAS. The Netherlands. http://www.das-score.nl/ (6 March 2012, date last accessed).
15. van Gestel AM, Prevoo ML, van 't Hof MA et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34-40.
16. Curtin F, Schulz P. Multiple correlations and Bonferroni's correction. Biol Psychiatry 1998;44:775-7.
17. Matsui T, Nakata N, Nagai S et al. Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis. J Nucl Med 2009;50:920-6.